Behavioral effects of (−)10, 11-methylenedioxy-n-n-propylnoraporphined, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines
- 1 October 1982
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 21 (10), 953-961
- https://doi.org/10.1016/0028-3908(82)90106-x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- An orally effective, long-acting dopaminergic prodrug: (−)-10,11-methylenedioxy-N-propylnoraporphineEuropean Journal of Pharmacology, 1982
- N-n-propyl-norapomorphine: An extremely potent stimulant of dopamine autoreceptorsBrain Research, 1982
- Pharmacology of [3H]apomorphine binding to bovine brain tissueBiochemical Pharmacology, 1981
- Oral bioavailability of apomorphine in the rat with a portacaval venous anastomosisEuropean Journal of Pharmacology, 1980
- Prolonged decrease of serum prolactin in rat by an ester prodrug of apomorphinePsychoneuroendocrinology, 1979
- Effects of alternative transmitter amines on cyclic AMP formation in rat brain tissueEuropean Journal of Pharmacology, 1979
- Hydrolysis of diester prodrugs of apomorphineBiochemical Pharmacology, 1977
- Behavioral effects of apomorphine and diisobutyrylapomorphine in the mousePsychopharmacology, 1977
- Prolonged apomorphine-like behavioural effects of apomorphine estersNeuropharmacology, 1976
- ERGOMETRINE AND APOMORPHINE AS SELECTIVE ANTAGONISTS OF DOPAMINE IN THE CANINE RENAL VASCULATUREBritish Journal of Pharmacology, 1974